Russ Cohen

Insights into Block (SQ) Stock Trading Before and After Q4 Earnings Decoding Block (SQ) Stock Behavior Surrounding Q4 Earnings

Block, Inc SQ experienced a surge of over 5% on Thursday, anticipating its upcoming fourth-quarter earnings release after the market closes.

The Last Earnings Performance

After Block outperformed expectations in its third-quarter earnings report on Nov. 2, the stock skyrocketed by 18%, eventually settling at 10% higher.

Projected Earnings for Q4

For the fourth quarter, analysts estimate Block’s earnings per share at 59 cents, with revenues expected to reach $5.699 billion.

Analyst Recommendations

Prior to the earnings announcement, Wedbush analyst Moshe Katri upgraded Block from Neutral to Outperform, setting a new price target of $90, up from $70.

Trading Strategies for Investors

Those looking to capitalize on potential gains in Block stock with diversification might consider a position in the AXS 2X Innovation ETF, which aims to mirror the performance of the ARK Innovation ETF, led by Cathie Wood, with a 6.02% Block weighting.

Alternatively, bearish traders can explore the AXS Short Innovation Daily ETF, designed to inversely track the performance of ARK Innovation ETF.

Technical Analysis and Trading Insights

From a technical perspective, Block’s stock appears neutral, having traded sideways since Jan. 3. Holding positions through earnings can be unpredictable, akin to gambling, as stock reactions may defy expectations.

Recent price action indicates a potential shift, with the stock showing patterns that traders are eyeing for bullish or bearish signals.

  • Optimistic traders hope for a bullish response post-earnings, confirming positive signals in price movements. This could help reverse any downward trends.
  • Pessimistic traders anticipate a negative earnings impact, leading to a drop below $62, signaling a continued downtrend.
  • Key resistance levels exist at $69.60 and $78.19, while support levels are seen at $62.50 and $53.97.
See also  Understanding the Investigation into Allarity Therapeutics, Inc.Exploring the Inquiry into Allarity Therapeutics, Inc.

Image by Samson on Unsplash